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E-mail addresses: mkteng@ustc.edu.cn (M. Teng), sHuman Pax2 transactivation domain-interacting protein (hPTIP), containing six BRCT domains, is an
essential protein required for the IR induced DDR process with an unclear role. Here we report that
the tandem BRCT5–BRCT6 domain of hPTIP recognizes the cH2AX tail, and this interaction depends
on the phosphorylation of H2AX Ser139 and binding with the carboxyl ending peptide to the ami-
noacyl ending peptide. The 2.15 Å crystal structure of hPTIP BRCT5/6–cH2AX complex and mutation
analysis provide molecular evidence for direct interactions between PTIP and cH2AX. This interac-
tion proffers a new clue to identify the role of PTIP in DDR pathways.
Structured summary of protein interactions:
PTIP and gamma H2AX bind by ﬂuorescence polarization spectroscopy (View Interaction: 1, 2, 3, 4, 5, 6).
PTIP and gamma H2AX bind by X-ray crystallography (View interaction).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction purpose of recruiting repair proteins to the DNA double-strandedTheDNAdamage response (DDR) is a basic cellular processwhich
is indispensable formaintaining genome stability [1]. Moreover, the
process is vitally important for cells and organisms function. Once
DNA was damaged by endogenous or exogenous factors during
different phases of cell cycle [2], many proteins can be recruited to
DNA lesion sites, where these proteins can compose a complex
network to activate DNA repair mechanisms. This process is trig-
geredbymembersof thephosphoinositide-3-kinase-relatedprotein
kinase (PIKK) family, such as ATM (ataxia telangiectasia mutated)
and ATR (ataxia telangiectasia and Rad3related) [3]. Histone H2A
variant (H2AX) is a componentof thenucleosomecore structure that
comprises 10–15% of total cellular H2A in higher organisms [4]. In
mammalian cells, histone variantH2AXC-terminal phosphorylation
is one of the ﬁrst chromatin modiﬁcations which occurs for thechemical Societies. Published by E
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achem@ustc.edu.cn (X. Li).breaks sites (DSBs) [5]. Particularly, the tandem BRCT (BRCA1 C-ter-
minal domain)-containing proteins, such as hMDC1, hMCPH1,
spBrc1 and spCrb2 (53BP1 homologue in Schizosaccharomyces pom-
be), may bind to phosphoH2AX (cH2AX) or phosphoH2A (cH2A, in
yeast), [6,7].
PTIP (Pax2 transactivation domain interaction protein), an inter-
actor of transcription factor Pax2 [8], has been demonstrated to be
associated with histone H3 lysine 4 trimethylation and human DDR
process [9,10]. PTIP contains six BRCT domains: two at the amino
terminus and the other four at the carboxyl terminus [11]. Previous
studies indicated that the second BRCT domain of PTIP can directly
interact with PA1 [12], and the four C-terminal BRCT domains are
needed for the foci formation after IR (ionizing radiation) and the
interaction with phosphated 53BP1 (Ser25) [11,13].
After DNA damage occurred, PTIP is accumulated at DSBs and
colocalizes with cH2AX [14]. Previous studies indicated that, this
kind of PTIP accumulation depends on the histone ubiquitylation
mediated by UBC13 and RNF8/RNF168 [15], but is independent of
53BP1orPA1 [12]. SincePTIPand its established interactionpartners
do not contain obvious ubiquitin binding motifs, how PTIP recruit-
ment associates with histone ubiquitylation remains obscure. Re-
cent report indicated that PTIP and PA1 can be corecruited to DSBs
and interact with the MLL histone methyltransferase [16,17], sug-
gesting a potential histone-modifying role of PTIP in DDR process.
By the oriented peptide library screen, PTIP BRCT5-BRCT6
domains (BRCT5/6) have been proved to be sufﬁcient for bindinglsevier B.V. All rights reserved.
Table 1




a, b, c (Å) 84.97, 101.81, 61.81
a, b, c () 90.00, 90.00, 90.00
Data collection statistics
Wavelength (Å) 0.9792
W. Yan et al. / FEBS Letters 585 (2011) 3874–3879 3875with a phospho-peptide pS/T-Q-V-F motif [14]. Since human
cH2AX C-terminal tail has a similar motif (pS-Q) corresponding
to the optimal BRCT5/6 binding sequence, and the C-terminal tan-
dem BRCT domains of Brc1 (PTIP homologue in S. pombe) can bind
to cH2A [18], it implies that PTIP could interact with cH2AX. The
ﬂuorescence polarization assays (FPA) demonstrated the binding
ability between BRCT5/6 and cH2AX in vitro, and the crystal struc-
ture of BRCT5/6–cH2AX tail complex at 2.15 Å resolution indicated
the molecular basis of cH2AX recognition by human PTIP BRCT5/6.Resolution (Å) 25–2.15 (2.15–2.19)
Unique reﬂections 29188 (1333)
Completeness (%) 97.9 (93.0)
Rmerge








RMSD bond lengths (Å) 0.007
RMSD bond angles () 1.028
Mean B factor (Å2) 35.2
Ramachandran plot
Most favored regions (%) 91.5
Additional allowed regions (%) 8.5
Disallowed regions (%) 0
PDB ID 3SQD
a Rmerge ¼
P jIi  hIi=
P jIjj, where Ii is the intensity of an individual reﬂection and
hIi is the average intensity of that reﬂection.
b Rfactor ¼
P jjFobs  jFcalcjj
P jFobsj for all reﬂections, Rfree was calculated on the
5% of data excluded from reﬁnement.2. Materials and methods
2.1. Cloning, expression, and puriﬁcation
The gene of human PTIP BRCT5/6 domains (residues 860–
1056aa) was cloned from human brain cDNA library by Polymerase
Chain Reaction. The PCR fragment was inserted into expression
vector pET28b (Novagen, modiﬁed) to create a recombinant pro-
tein with a hexahistidine tag (MGHHHHHH) at the N-terminus.
The plasmid was then transformed into E. coli BL21/Gold (DE3)
(Novagen) competent cells. The transformant was grown in Lur-
ia–Bertani (LB) medium containing 50 lg/ml kanamycin at 310 K.
Until OD600 of 0.8  1.0 was reached, 0.1 mM isopropyl-b-D-thioga-
lactopyranoside (IPTG) was added for induction. After 24 h induc-
tion at 289 K, cells were harvested by centrifugation. Harvested
cells were suspended in buffer A (containing 25 mM Tris–HCl pH
8.5, 1 M NaCl) and lysed by soniﬁcation on ice. Cell lysate was cen-
trifuged at 14,000 rpm for 30 min at 277 K. The clear supernatant
was puriﬁed on Ni–NTA column (QIAGEN), and further puriﬁcation
was achieved on a Superdex 200 (GE Healthcare) gel ﬁltration
chromatography column. The puriﬁed protein was then dialysised
into buffer B (containing 10 mM Tris–HCl pH 8.0, 100 mM NaCl,
1 mM EDTA, and 1 mM b-mercaptoethanol). Mutations of PTIP
BRCT5/6 were obtained using PCR as the protocol in MutanBEST
kit (TaKaRa). Mutant proteins were puriﬁed using the same proce-
dure as that for the wild-type protein.
2.2. Crystallization and data collection
The native PTIP BRCT5/6 protein and the protein-peptide com-
plex (prepared by mixing tandem BRCT5/6 domains with cH2AX
phosphopeptide (KKATQA-pS-QEY-COO-) at 1:3 mol ratio) were
concentrated to 5 mg/ml (OD280 with the molar absorption coefﬁ-
cient 17420 M1cm1, Eppendorf BioPhotometer Plus) by centrifu-
gal ultraﬁltration (Millipore, 3 kDa cutoff) prior to crystallization
trials. The native protein failed to crytallization by hanging-drop
vapour-diffusion method, but the crystals of the protein–peptide
complex were grown in the precipitant solution containing 18%
(w/v) PEG4000 and 100 mM Nacacodylate pH 6.0 at 287 K. The
protein–peptide complex crystals were soaked brieﬂy into cryo-
protectant solution containing corresponding reservoir solution
supplemented with 30% (v/v) glycerol prior to data collection. X-
ray diffraction data were collected on beamline 17U1 of the Shang-
hai Synchrotron Radiation Facility (SSRF) using a Jupiter CCD
detector. All frames were collected at 100 K. All diffraction data
were processed and scaled with HKL2000 [19].
2.3. Phase determination and structure reﬁnement
The phase problem of the complex was solved by molecular
replacement method using structure of S. pombe Brc1 (PDB entry
3L40 [18]) as an initial search model with MOLREP in the CCP4
package [20]. The model was further built and reﬁned using Ref-
mac5 [21] and COOT [22] by manual model correction. Waters
adding and the ﬁnal reﬁnement was executed in Phenix reﬁne[23]. The stereochemical quality of the ﬁnal model was checked
with the program PROCHECK [24].
Data collection and reﬁnement statistics are listed in Table 1. All
ﬁgures were prepared using PyMOL (<http://www.pymol.org/>).
2.4. Fluorescence polarization assays
The sequences of ﬂuorescently labeled (FITC) peptides (synthe-
sized by GL Bichem shanghai Ltd) are listed as follows: H2AX
(KKATQASQEY-COO-), cH2AX (KKATQA-pS-QEY-COO-), cH2AX
with amidation of the C-terminus (KKATQA-pS-QEY-CONH2). FPA
were performed in Tris–HCl buffer (20 mM Tris pH 8.0, 100 mM
NaCl, and 1 mM EDTA) using a SpectraMax M5 Microplate Reader
system at 293 K. The wavelengths of ﬂorescence excitation and
emission were 485 nm and 538 nm, respectively. Each 96-well
contained 30 nM FITC-labeled peptide and with PTIP BRCT5/6
(concentrations from 0 to 50 lM) in a ﬁnal volume of 200 ll. For
each assay, protein-only controls were included. The ﬂuorescence
polarization P (in mP units) was calculated with Eq. (1)
P ¼ ðI==  I?Þ=ðI== þ I?Þ ð1Þ
The ﬂuorescence polarization change DP (in mP units) was ﬁtted to
Eq. (2)
DP ¼ DPmax  ð½protein=ðKd þ ½proteinÞÞ ð2Þ
The binding curves were ﬁtted according to a one-site binding mod-
el using ORIGIN software (<http://www.originlab.com>).
2.5. CD spectroscopy
The puriﬁed PTIP BRCT5/6 and its mutants (0.1 mg/ml) in
30 mM sodium phosphate buffer (pH 8.0) were loaded into a
quartz cuvette (d = 0.1 cm path length) and CD spectra from 190
to 250 nm were recorded on a Jasco-810 spectropolarimeter at
298 K. A buffer-only sample was used as reference. All CD spectra
were the average of three successive spectra. The molar ellipticities
Fig. 1. PTIP BRCT5/6 domains bind cH2AX peptide in vitro. (A) Sequences alignment among the PTIP three tandem BRCT domains and other tandem BRCT domains. Results
indicate only BRCT5/6 has the conserved residues (red boxes and triangles) that can recognize phosphorylated peptide. (B) FPA of PTIP BRCT 5/6 with FITC labled cH2AX and
H2AX peptide. (C) The CD spectra of recombinant PTIP BRCT5/6 domains and its mutants.
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subtracted from each curve (Fig. 1C).3. Results
3.1. Phosphorylated H2AX peptide recognition by PTIP BRCT5/6
domains
Sequences alignment among the PTIP tandem BRCT domains
(BRCT1/2, BRCT3/4, and BRCT5/6) and the phosphorylated peptide
recognition BRCT domains (from hMdc1, hBrca1, spCrb2 and
spBrc1, respectively) indicated that, only PTIP BRCT5/6 contained
the conserved phosphorylated peptide recognition residues
(Fig. 1A). FPA were performed to measure the cH2AX binding abil-
ity of PTIP BRCT5/6. The dissociation constant (Kd) between the PTIP
BRCT5/6 and cH2AX (KKATQA-pS-QEY-COO) was approximately
1.69 ± 0.14 lM, which was similar to other BRCT–phosphopeptide
interactions (such as the Kd between spBrc1 BRCT5/6 and cH2A
was approximately 2.6 lM) [25–26]. The Kd between the PTIP
BRCT5/6 and cH2AX (KKATQApSQEY-CONH2) was approximately
23.6 ± 1.9 lM, indicated a lower speciﬁcity for the amidated C-ter-
minus of cH2AX peptide. In contrast to that, the interaction be-
tween PTIP BRCT5/6 and H2AX peptide was not detected by the
same method (Fig. 1B). This illustrated that the recognition be-
tween PTIP BRCT5/6 and H2AX peptide was phosphorylation
dependent, and the free COOH-terminus of cH2AX also contributed
to the speciﬁc interaction with PTIP.3.2. Crystal structure of PTIP BRCT5/6–cH2AX tail complex
The PTIP BRCT5/6–cH2AX complex structure was determined
by molecular replacement method using the structure of spBrc1
(PDB: 3L40) as a search model and reﬁned to 2.15 Å resolution.In this structure, each BRCT domain comprises a central parallel
b-sheet that is ﬂanked by two helices (a1 and a3) on one side, and
by helix a2 on the other side. However, BRCT6 has another single
helical element (aI0) in front of b20 sheet. The linker of BRCT5/6
adopts a helix-loop-helix structure, which can stabilize the inter-
BRCT interface. The two BRCT domains pack closely against each
other in a head-to-tail manner through a large hydrophobic inter-
face, creating a deep surface groove. The phosphorylated H2AX
peptide sits in the groove, interacting with residues from both
BRCT5 and BRCT6 (Fig. 2A). Due to the different interaction envi-
ronment, the number of residues of each peptide are ordered in
the X-ray structure in each of the two molecules of the asymmetric
unit is different. One covers full length phosphopeptide (Lys133-
Tyr142), the other covers partial length phosphopeptide (Ser139-
Tyr142) (Fig. 2B). The trend of Lys133-Ala138 residues of one
cH2AX peptide (Yellow) is ﬁxed by the interaction with another
BRCT5/6 (Blue) from the adjacent asymmetric. The other peptide
(Green) only interacts the BRCT5/60 (Palecyan) with Ser139-
Tyr142 residues, and the ﬂexible Lys133-Ala138 region doesnot
indicate the ﬁxed electron density in the structure. Difference fou-
rier maps revealed well-deﬁned electron density for the full phos-
phopeptide, covering cH2AX Lys133-Tyr142 (Fig. 2C). View from
electrostatic surface of PTIP BRCT5/6, the phosphate group of
cH2AX binds in a small basic pocket, the Tyr142 (pSer+ 3) sits
above the hydrophobic interface (Fig. 2D). PTIP BRCT5/6–cH2AX
interaction results in burying approximately 360.645 Å2 of solvent
accessible surface area.
Despite low sequence identity with other tandem BRCT domains
(32% with the C terminal tandem BRCT domain of hMDC1, 28% with
the C terminal tandem BRCT domain of spBrc1), structural compar-
ison indicates that the overall structure of PTIP is very similar to
that of the canonical tandemBRCT domains (an rmsd of 1.19 Å com-
pared with the hMDC1 tandem BRCT domains on Ca positions for
151 residues, and 1.29 Å compared with the spBrc1 tandem BRCT
Fig. 2. Crystal structure of PTIP BRCT5/6–cH2AX complex. (A) Stereo view of PTIP BRCT5/6–cH2AX tail complex. The cH2AX peptide (yellow stickmodel) binds at the interface
between the BRCT5 (marine) and BRCT6 (green) domain. The BRCT-linker is colored cyan. (B) TwocH2AXpeptides in one asymmetric unit display different lengths. (C) The (2Fo-
Fc) electron densitymap at 1r of the cH2AX tail peptide. (D) Charge complementarity between the acid cH2AX phospho-peptide and a basic patch (blue) on the surface of PTIP,
tworegionsare labeledwithyellowdottedcircle. (E)Overall structure superpositionofhPTIPBRCT5/6 (Red), hMDC1(PDBcode2ADO) (Cyan), andspBrc1 (PDBcode3L40) (green).
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sideration of that spBrc1 includes a same insertion helix aI0 in front
of b20 sheet like PTIP but hMDC1 does not contain the similar motif
(Fig. 2E), PTIP may be considered to be more closely related to
spBrc1 at the domain structure level than hMDC1.3.3. Conserved cH2AX peptide binding pocket of PTIP BRCT5/6 domains
Like spBrc1-cH2A complex, PTIP BRCT5/6–cH2AX interaction
indicates a classical ‘two-knob’ model present in other tandem
BRCT-phosphopeptide interactions.
Fig. 3. Conserved cH2AX binding pocket of PTIP. (A) The phosphoSer binding pocket of PTIP BRCT5/6. The residues involved are labeled. Important hydrogen bonds are
indicated with dashed lines. (B) The phosphoSer binding pocket of Brc1 (PDB code 3L41).(C) FPA of PTIP BRCT5/6 WT, T872A and K913M mutation binding with FITC labeled
cH2AX peptide. (D) The pSer +2 and pSer +3 (Tyr) binding pocket of PTIP. The residues involved also are labeled. (E) The pSer +2 and pSer +3 (Leu) binding pocket of
Brc1(3L41). (F) FPA of PTIP BRCT5/6 WT, T1054A, E1050A and R910D binding with FITC labeled cH2AX peptide.
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pSer139 phosphate group of cH2AX (corresponding to pSer129 of
cH2A) and PTIP Thr872, Lys913 side chains and Gly873 backbone
amide nitrogen (corresponding to residues Thr672, Lys710 and
Gly673 of spBrc1 respectively) (Fig. 3A–B). FPA indicates that both
T872A and K913M mutations of PTIP BRCT5/6 lose most interac-
tion ability with the cH2AX peptide, conﬁrming the indispensable
role of Thr872 and Lys913 in the phosphoSer recognition (Fig. 3C).
The second knob is made up by the interactions between the C
terminus of cH2AX (Glu141-Tyr142) and the BRCT5/6 interface
hydrophobic groove. The carboxylate group of Glu141 (pSer +2,
corresponding to Glu131 of cH2A) interacts with side chain ofThr909 by hydrogen bond and forms a water mediated salt bridge
with Lys907 (corresponding to Arg704 of spBrc1). Because the PTIP
b10–a10 loop substitutes for the extended 310 helix that surrounds
the pSer +3 binding site in spBrc1-cH2A complex, the phenolic side
chain of PTIP Tyr142 (pSer +3, corresponding to Leu132 of cH2A)
hydrogen-bond interacts with the nitrogen of peptide-bond be-
tween Pro986 and Ser987 (mediated by a water molecule), instead
the hydrophobic interaction with Asn788, Ala791 and Ile795 from
the extended 310 helix in spBrc1-cH2A complex. Tyr142 backbone
amide nitrogen forms a hydrogen bond with carbonyl oxygen of
Arg910 backbone (corresponding to Arg707 of spBrc1), and the free
C terminus carboxylate forms a complex hydrogen-bond and salt-
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ate group of Glu1050 and even the hydroxyl group of Thr1054
(Fig. 3D–E). FPA indicates that R910D mutation signiﬁcantly lose
cH2AX peptide binding ability (Kd = 357 lM), E1050A mutation
also decreased markedly (Kd = 11.3 ± 0.48 lM), but T1054A
mutation displayed no distinct inﬂuence for it (Kd = 1.0 ± 0.08 lM)
(Fig. 3F). These results indicate that Arg910 is critical for cH2AX
peptide recognition, and Glu1050 may act the assistant role for
the interaction between PTIP and the free C terminus carboxylate
of cH2AX. Based on above conclusions, the amidation of cH2AX
C-terminus would change the residue charge from negative to neu-
tral and disrupt the salt bridge interaction, and the larger amino-
acyl group would also make additional steric hindrance to
obstruct the peptide recognition.
The far-UV CD spectra of these mutant proteins were similar to
which of wild-type protein, suggesting that all of the above muta-
tions were well-folded during the recombinant expression process.
4. Discussion
For the ﬁrst time, we demonstrate that PTIP BRCT5/6 interacts
tightly with cH2AX peptide absolutely depends on the phosphory-
lation of H2AX Ser139 in vitro, and the binding ability is similar to
other BRCT-phosphopeptide interactions (such as that of spBrc1
BRCT5/6 and cH2A). The 2.15 Å X-ray structure of PTIP-cH2AX
complex reveals a conserved domain organization characteristic
and high structural similarity to that of spBrc1-cH2A complex,
implying that PTIP and spBrc1 would be a pair of distant functional
homologs. The different pSer +3 binding site conﬁgurations of these
two complexes indicate that, PTIP tending to bind polar side chain
(Tyr) much than non-polar aliphatic side chain (Leu) at the pSer +3
binding site. Additionally, a signiﬁcant difference of binding
strength between PTIP BRCT5/6 and the carboxyl end or the amino-
acyl end of phosphorylated peptide indicates that, PTIP BRCT5/6
prefer to bind phosphorylated serine near the C terminus (such as
cH2AX) much than pSer locates on the middle of peptide (such as
53BP1), which coincide with the actually low interaction ability be-
tween PTIP BRCT5/6 and the phosphorylated 53BP1 (p53BP1) [13].
The interaction between PTIP BRCT5/6 and cH2AX provides new
clues to identify the role of PTIP in DDR pathways. Because the
co-localization of PTIP with cH2AX depends on RNF8/168-UBC13-
mediated histone ubiquitylation in vivo [15], the direct interaction
between PTIP and cH2AX, that was mapped in the absence of any
other factors in vitro, may be insufﬁcient to recruit PTIP to the
DSB-surrounding chromatin. ConsideringPTIP contains six BRCTdo-
mains and a glutamine-rich region, and has been conﬁrmed that
could interact with variant DDR factors (such as p53BP1, PA1 and
cH2AX etc.) in DDR pathways, PTIP would act as an assembly plat-
form for chromatin modulation or DSBs repair, in concert with
53BP1andcH2AX. The co-localizationof PTIPwithcH2AXmayneed
some assists from PTIP recruiting component, and the interaction
between PTIP BRCT5/6 and cH2AX may facilitate the interworking
of DDR factors which are recruited by both PTIP and cH2AX.
4.1. PDB accession number
Atomic coordinate and structure factor of PTIP BRCT5/6–cH2AX
complex have been deposited in the Protein Data Bank under
accession number 3SQD.
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